AZD0486 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-13 in 5mo
ESTIMATED |
READOUT
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Phase 1/2 · B-cell Acute Lymphoblastic Leukemia (B-ALL) |
AZN ASTRAZENECA PLC | AZD0486 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|